These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 13681321)

  • 1. [The pharmacological properties of a new bismuth salt: the bismuth-sulfamethoxypyridazine complex].
    ADAMI E; PICCININI F; MARAZZI-UBERTI E
    Arzneimittelforschung; 1961 Jun; 11():549-51. PubMed ID: 13681321
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative studies on the properties of sulfamethoxypyridazine and other prolonged action sulfonamides].
    TEUCHMANN JK; KOROLKIEWICZ Z; KUCHCINSKI W
    Pol Tyg Lek; 1960 Dec; 15():1958-62. PubMed ID: 13776129
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sensitivity of 220 strains of gram-negative bacilli to sulfamethoxypyridazine].
    WLODARCZAK K; JELJASZEWICZ J
    Med Dosw Mikrobiol; 1960; 12():67-70. PubMed ID: 13845536
    [No Abstract]   [Full Text] [Related]  

  • 4. [Raising of the blood penicillin level with sulfamethoxypyridazine].
    SARMIENTO J; MONTES G
    Rev Fac Med Univ Nac Colomb; 1961; 29():53-8. PubMed ID: 14497258
    [No Abstract]   [Full Text] [Related]  

  • 5. Laboratory experiences with sulfamethoxypyridazine.
    LITCHFIELD JT
    Antibiot Chemother; 1960; 8():2-16. PubMed ID: 13762704
    [No Abstract]   [Full Text] [Related]  

  • 6. [The sensitivity to sulfamethoxypyridazine of 20 strains of meningococci isolated from the Niger in 1961].
    CHABBERT Y
    Bull Soc Pathol Exot Filiales; 1961; 54():976-8. PubMed ID: 13877817
    [No Abstract]   [Full Text] [Related]  

  • 7. [On some pharmacodynamic characteristics of the association of sulfamethoxypyridazine and iodine].
    QUATTRIN N; BRANCACCIO A; D'ALESSANDRO B
    Clin Ter; 1961 Mar; 20():245-52. PubMed ID: 13738651
    [No Abstract]   [Full Text] [Related]  

  • 8. [Behavior of the urinary reducing power after administration of isoniazid, penicillin, cycloserine and sulfamethoxypyridazine].
    D'AGOSTINO S; MADDALUNO R; GIOVAGNOLI P
    Clin Ter; 1962 Jul; 23():48-56. PubMed ID: 13882935
    [No Abstract]   [Full Text] [Related]  

  • 9. A new sulfonamide combination designed for treatment of kidney and urinary tract infections: its blood concentration and renal excretion.
    HOLMGARD A; JOSEPHSON B; BUCHT H; ORSTEN PA
    Curr Ther Res Clin Exp; 1961 Sep; 3():397-404. PubMed ID: 13715486
    [No Abstract]   [Full Text] [Related]  

  • 10. Syntheses, crystal structures and antimicrobial activities of monomeric 8-coordinate, and dimeric and monomeric 7-coordinate bismuth(III) complexes with tridentate and pentadentate thiosemicarbazones and pentadentate semicarbazone ligands.
    Nomiya K; Sekino K; Ishikawa M; Honda A; Yokoyama M; Chikaraishi Kasuga N; Yokoyama H; Nakano S; Onodera K
    J Inorg Biochem; 2004 Apr; 98(4):601-15. PubMed ID: 15041240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Action of a sulfonamide (3-sulfanilamido-6-methoxypyridazine) on the serum level of properdin].
    GRECO M; COLALONGO G
    Boll Soc Ital Biol Sper; 1961 Apr; 37():296-8. PubMed ID: 13708145
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the antitrypanosomal action of hydrosoluble compounds of bismuth].
    FERRARI M
    Boll Ist Sieroter Milan; 1961; 40():61-4. PubMed ID: 13699056
    [No Abstract]   [Full Text] [Related]  

  • 13. Bismuth uptake in rat testicular macrophages: a follow-up observation suggesting that bismuth alters interactions between testicular macrophages and Leydig cells.
    Stoltenberg M; Hutson JC
    J Histochem Cytochem; 2004 Sep; 52(9):1241-3. PubMed ID: 15314091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectroscopic characterization of extracellular polymeric substances from Escherichia coli and Serratia marcescens: suppression using sub-inhibitory concentrations of bismuth thiols.
    Badireddy AR; Korpol BR; Chellam S; Gassman PL; Engelhard MH; Lea AS; Rosso KM
    Biomacromolecules; 2008 Nov; 9(11):3079-89. PubMed ID: 18937399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Report on the antibiotic activity of the DAN-352 compound].
    Arcalís L; Caldés J
    Microbiol Esp; 1967; 20(3):245-9. PubMed ID: 5619843
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the pharmacokinetics of bismuth compounds].
    Coghi S; Bonisoli-Alquati D; Raspa A; Vettori G
    Boll Soc Ital Biol Sper; 1968 Feb; 44(3):182-6. PubMed ID: 4972121
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bismuth in the Allium test: a problem in comparative toxicology].
    Bournique CP; Deysson G
    Ann Pharm Fr; 1976; 34(5-6):193-8. PubMed ID: 999156
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibacterial activity and absorption of sulphenazone.
    Rosini S
    Acta Paediatr Acad Sci Hung; 1972; 13(3):221-4. PubMed ID: 4652502
    [No Abstract]   [Full Text] [Related]  

  • 19. A 1:2-dihydro-s-triazine with marked activity against certain pathogenic bacteria and synergistic with a sulphonamide in experimental bacterial infections.
    FISHER MW; DOUB L
    Biochem Pharmacol; 1959 Dec; 3():10-7. PubMed ID: 13823239
    [No Abstract]   [Full Text] [Related]  

  • 20. Peptic ulcers induced in white rats by reserpine and stress. The protective action of roterized bismuth subnitrate.
    DAMRAU F
    Am J Gastroenterol; 1961 Jun; 35():612-8. PubMed ID: 13719542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.